• To promote and educate pharmaceutical industry and regulatory bodies around the world that BFS technology can be considered an advanced aseptic manufacturing process for filling of liquid drug products.
  • To achieve common understanding worldwide on how BFS technology should be applied routinely to ensure drug products of the required quality, safety & efficacy are consistently produced.
  • To educate members about current and proposed future guidelines relevant to BFS technology to ensure continuous regulatory compliance.
  • To facilitate networking between BFS experts and peers on technical and regulatory matters.